The study is sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), and conducted by the NCI funded Experimental Therapeutics Clinical Trials Network, under ...
The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...
The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...
MADRID, Spain and CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop ...
The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...
MADRID and CAMBRIDGE, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop ...
Peeples Cancer Institute at Hamilton Medical Center has expanded access to the latest in cancer research for patients in north Georgia and the surrounding area by opening National Cancer Institute ...
The National Cancer Policy Forum, in collaboration with the American Society of Clinical Oncology, hosted a workshop to examine efforts to implement recommendations from the 2010 IOM consensus report, ...
Saint Luke’s Cancer Institute, part of Kansas City, Mo.-based Saint Luke’s Health System, will become a clinical trials affiliate of the Washington University School of Medicine in St. Louis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback